Your Cart ( 8 Items )

• Adjunctive Use of Calcipotriene 0.005%/Betamethasone Dipropionate 0.064% Foam in Patients With Psoriasis Treated With Ixekizumab
  March 2022 | Volume 21 | Issue 3 | Original Article | 235 | Copyright © March 2022
  Jerry Bagel MD MS, Elise Nelson LPN CCRC
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs
• Infliximab-Induced Psoriasis in Treatment of Crohn's Disease-Associated Ankylosing Spondylitis: Case Report and Review of 142 Cases
  August 2013 | Volume 12 | Issue 8 | Original Article | 939 | Copyright © August 2013
  Shannon Famenini BS^a and Jashin J. Wu MD^b
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs
• Clinical and Histopathologic Correlation of an Eruption Secondary to Taxotere
  December 2010 | Volume 9 | Issue 12 | Case Reports | 1534 | Copyright © December 2010
  Kenneth Beer MD PA and Hillary Oakley PA C
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs
• Part 1 of a 2 Part Article: A Comprehensive Review of Imatinib Mesylate (Gleevec) for Dermatological Diseases
  February 2006 | Volume 5 | Issue 2 | Original Article | 117 | Copyright © February 2006
  Noah Scheinfeld MD
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs
• Vismodegib for Locally Advanced Basal Cell Carcinoma: Descriptive Analysis of a Case Series and Comparison to the Literature
  September 2015 | Volume 14 | Issue 9 | Original Article | 956 | Copyright © September 2015
  Kathleen Sikora Viscusi MD and C. William Hanke MD MPH
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs
• Trends in Oral Antibiotic Use for Acne Treatment: A Retrospective, Population-Based Study in the United States, 2014 to 2016
  March 2023 | Volume 22 | Issue 3 | Original Article | 265 | Copyright © March 2023
  Ayman Grada MD^a,b, April Armstrong MD^c, Christopher G. Bunick MD PhD^d, Raidah J. Salem PharmD^e, Steven R. Feldman MD PhD^f
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs
• Efficacy, Safety, and Tolerability of a Halobetasol 0.01% /Tazarotene 0.045% Fixed Combination in the Treatment of Severe Localized Plaque Psoriasis: Post Hoc Analysis of Two Phase III Randomized Controlled Trials
  October 2019 | Volume 18 | Issue 10 | Original Article | 1012 | Copyright © October 2019
  

  Mark G. Lebwohl MD,ª Jeffrey L. Sugarman MD PhD,B Linda Stein Gold MD,c Tina Lin PharmD,d Robert Israel MDe

  
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs
• Stratum Corneum Permeation and PercutaneousDrug Delivery of Hydrophilic MoleculesEnhanced by Cryopneumatic andPhotopneumatic Technologies
  December 2010 | Volume 9 | Issue 12 | Original Article | 1528 | Copyright © December 2010
  Feng Sun PhD, Robert Anderson PhD, Guillermo Aguilar PhD
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs